Functional role of T-type calcium channels in tumour growth and progression: prospective in cancer therapy

Por Santoni, Giorgio, Santoni, Matteo, Nabissi, Massimo
Publicado em 2012

Prophylactic use of mTOR inhibitors and other immunosuppressive agents in heart transplant patients

Por Santoni, Matteo, Massari, Francesco, Cascinu, Stefano
Publicado no Cell Mol Immunol (2015)

Altering macrophage polarization in the tumor environment: the role of response gene to complement 32

Por Santoni, Matteo, Cascinu, Stefano, Mills, Charles D
Publicado no Cell Mol Immunol (2015)

Neoadjuvant Therapy in Pancreatic Cancer: An Emerging Strategy

Por Bittoni, Alessandro, Santoni, Matteo, Lanese, Andrea, Pellei, Chiara, Andrikou, Kalliopi, Stefano, Cascinu
Publicado em 2014

Danger- and pathogen-associated molecular patterns recognition by pattern-recognition receptors and ion channels of the transient receptor potential family triggers the inflammasom...

Por Santoni, Giorgio, Cardinali, Claudio, Morelli, Maria Beatrice, Santoni, Matteo, Nabissi, Massimo, Amantini, Consuelo
Publicado no J Neuroinflammation (2015)

The role of transient receptor potential vanilloid type-2 ion channels in innate and adaptive immune responses

Por Santoni, Giorgio, Farfariello, Valerio, Liberati, Sonia, Morelli, Maria B., Nabissi, Massimo, Santoni, Matteo, Amantini, Consuelo
Publicado em 2013

Capsaicin triggers autophagic cell survival which drives epithelial mesenchymal transition and chemoresistance in bladder cancer cells in an Hedgehog-dependent manner

Por Amantini, Consuelo, Morelli, Maria Beatrice, Nabissi, Massimo, Cardinali, Claudio, Santoni, Matteo, Gismondi, Angela, Santoni, Giorgio
Publicado no Oncotarget (2016)

Pathogenic and Diagnostic Potential of BLCA-1 and BLCA-4 Nuclear Proteins in Urothelial Cell Carcinoma of Human Bladder

Por Santoni, Matteo, Catanzariti, Francesco, Minardi, Daniele, Burattini, Luciano, Nabissi, Massimo, Muzzonigro, Giovanni, Cascinu, Stefano, Santoni, Giorgio
Publicado em 2012

Progress of Molecular Targeted Therapies for Advanced Renal Cell Carcinoma

Por Conti, Alessandro, Santoni, Matteo, Amantini, Consuelo, Burattini, Luciano, Berardi, Rossana, Santoni, Giorgio, Cascinu, Stefano, Muzzonigro, Giovanni
Publicado em 2013

Incidence and relative risk of hepatic toxicity in patients treated with anti-angiogenic tyrosine kinase inhibitors for malignancy

Por Iacovelli, Roberto, Palazzo, Antonella, Procopio, Giuseppe, Santoni, Matteo, Trenta, Patrizia, De Benedetto, Angelina, Mezi, Silvia, Cortesi, Enrico
Publicado em 2014

Does prostate acinar adenocarcinoma with Gleason Score 3 + 3 = 6 have the potential to metastasize?

Por Montironi, Rodolfo, Scarpelli, Marina, Mazzucchelli, Roberta, Lopez-Beltran, Antonio, Santoni, Matteo, Briganti, Alberto, Montorsi, Francesco, Cheng, Liang
Publicado em 2014

Axitinib induces DNA damage response leading to senescence, mitotic catastrophe, and increased NK cell recognition in human renal carcinoma cells

Por Morelli, Maria Beatrice, Amantini, Consuelo, Santoni, Matteo, Soriani, Alessandra, Nabissi, Massimo, Cardinali, Claudio, Santoni, Angela, Santoni, Giorgio
Publicado no Oncotarget (2015)

Axitinib induces senescence-associated cell death and necrosis in glioma cell lines: The proteasome inhibitor, bortezomib, potentiates axitinib-induced cytotoxicity in a p21(Waf/Ci...

Por Morelli, Maria Beatrice, Amantini, Consuelo, Nabissi, Massimo, Cardinali, Claudio, Santoni, Matteo, Bernardini, Giovanni, Santoni, Angela, Santoni, Giorgio
Publicado no Oncotarget (2016)

Protracted low doses of temozolomide for the treatment of patients with recurrent glioblastoma: A phase II study

Por SANTONI, MATTEO, PACCAPELO, ALESSANDRO, BURATTINI, LUCIANO, BIANCONI, MARISTELLA, CARDINALI, MASSIMO, FABBIETTI, LETIZIA, TRIGNANI, ROBERTO, RYCHLICKI, FRANCO, CASCINU, STEFANO
Publicado em 2012

CXC and CC Chemokines as Angiogenic Modulators in Nonhaematological Tumors

Por Santoni, Matteo, Bracarda, Sergio, Nabissi, Massimo, Massari, Francesco, Conti, Alessandro, Bria, Emilio, Tortora, Giampaolo, Santoni, Giorgio, Cascinu, Stefano
Publicado em 2014

Clinical outcomes in patients with metastatic renal cell carcinoma receiving everolimus or temsirolimus after sunitinib

Por Iacovelli, Roberto, Cartenì, Giacomo, Milella, Michele, Berardi, Rossana, Di Lorenzo, Giuseppe, Verzoni, Elena, Rizzo, Mimma, Santoni, Matteo, Procopio, Giuseppe
Publicado em 2014

Loss of TRPV2 Homeostatic Control of Cell Proliferation Drives Tumor Progression

Por Liberati, Sonia, Morelli, Maria Beatrice, Amantini, Consuelo, Farfariello, Valerio, Santoni, Matteo, Conti, Alessandro, Nabissi, Massimo, Cascinu, Stefano, Santoni, Giorgio
Publicado em 2014

Correction: Liberati, S., et al. Loss of TRPV2 Homeostatic Control of Cell Proliferation Drives Tumor Progression. Cells 2014, 3, 112–128

Por Liberati, Sonia, Morelli, Maria Beatrice, Amantini, Consuelo, Farfariello, Valerio, Santoni, Matteo, Conti, Alessandro, Nabissi, Massimo, Cascinu, Stefano, Santoni, Giorgio
Publicado em 2014

Post-transcriptional regulation of 5'-untranslated regions of human Transient Receptor Potential Vanilloid type-1 (TRPV-1) channels: role in the survival of glioma patients

Por Nabissi, Massimo, Morelli, Maria Beatrice, Arcella, Antonietta, Cardinali, Claudio, Santoni, Matteo, Bernardini, Giovanni, Santoni, Angela, Santoni, Giorgio, Amantini, Consuelo
Publicado no Oncotarget (2016)

Bone metastases affect prognosis but not effectiveness of third-line targeted therapies in patients with metastatic renal cell carcinoma

Por Iacovelli, Roberto, Santini, Daniele, Rizzo, Mimma, Felici, Alessandra, Santoni, Matteo, Verzoni, Elena, Masini, Cristina, Massari, Francesco, Calvani, Nicola, Mosca, Alessandra, Procopio, Giuseppe
Publicado no Can Urol Assoc J (2015)